1. 2107 Safety and efficacy on TAS-102 monotherapy in patients with metastatic colorectal cancer according to previous regorafenib. (September 2015) Authors: Kotani, D.; Shitara, K.; Fukuoka, S.; Kuboki, Y.; Bando, H.; Okamoto, W.; Kojima, T.; Doi, T.; Ohtsu, A.; Yoshino, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2297 Clinical features of exceptional responders with unresectable and metastatic gastric cancers by palliative chemotherapy: A long follow-up. (September 2015) Authors: Nakamura, Y.; Shitara, K.; Shibasaki, H.; Kinoshita, T.; Shimada, K.; Fuse, N.; Doi, T.; Ohtsu, A.; Yoshino, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2312 Japanese phase I trial of hypoxia-activated prodrug evofosfamide (TH-302) as monotherapy in patients with solid tumors or in combination with gemcitabine in patients with advanced pancreatic cancer. (September 2015) Authors: Mitsunaga, S.; Takahashi, H.; Doi, T.; Johne, A.; Wang, J.; Shimizu, A.; Ikeda, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2328 Outcomes in 44 Patients with metastatic esophageal squamous cell carcinoma treated in phase 1 trials: the NCCHE Experience. (September 2015) Authors: Noguchi, M.; Kojima, T.; Shitara, K.; Kawazoe, A.; Fukuoka, S.; Kuboki, Y.; Hatogai, K.; Bando, H.; Okamoto, W.; Doi, T.; Ohtsu, A.; Yoshino, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2405 Comprehensive biomarker analyses in esophageal squamous cell carcinoma. (September 2015) Authors: Hatogai, K.; Fujii, S.; Kojima, T.; Daiko, H.; Nomura, S.; Doi, T.; Ochiai, A.; Yoshino, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2542 Safety and efficacy of radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases. (September 2015) Authors: Uemura, Hirotsugu; Uemura, Hiroji; Matsubara, N.; Kaneko, M.; Doi, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 3430 Clinical outcomes in 21 patients with gastrointestinal stromal tumor (GIST) treated in phase I trials: The NCCHE Experience. (September 2015) Authors: Nagatani, Y.; Shitara, K.; Bando, H.; Okamoto, W.; Kojima, T.; Yoshino, T.; Nishida, T.; Doi, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 365 Identification of the recommended phase II dose (RP2D) of the c-Met Inhibitor tepotinib (MSC2156119J) in Japanese patients (pts) with solid tumors: A phase I trial. (September 2015) Authors: Yamazaki, K.; Tsushima, T.; Shitara, K.; Sarholz, B.; Fujita, M.; Doi, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028. (September 2015) Authors: Bang, Y.J.; Doi, T.; Braud, F. De; Piha-Paul, S.; Hollebecque, A.; Razak, A.R. Abdul; Lin, C.C.; Ott, P.A.; He, A.R.; Yuan, S.S.; Koshiji, M.; Lam, B.; Aggarwal, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Active oils, comparator oils, and study populations as explanations for contrasting results of reduce-it vs. strength: copenhagen general population study mimicking trial designs. (August 2021) Authors: Doi, T.; Langsted, A.; Nordestgaard, B.G. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗